EIF3KP2

Across TCGA pan-cancer cohorts, EIF3KP2 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated EIF3KP2 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher EIF3KP2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated EIF3KP2 expression acts as an unfavorable survival marker, although some lineages such as DLBC and LUAD show a favorable association.

DLBC, STAD, and CESC are the cancer types where EIF3KP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Median	All	1.000	0.808	.007	35	view →
STAD	DFS	Quartile	All	0.428	0.687	.016	15	view →
CESC	DFS	Tertile	All	0.629	0.759	.012	14	view →
LUAD	OS	Tertile	All	0.487	0.293	.013	13	view →
ESCA	DFS	Quartile	IV	0.826	0.284	.049	12	view →
MESO	OS	Median	IV	0.197	0.726	<.001	12	view →
READ	OS	Tertile	IV	0.423	0.917	<.001	9	view →
CHOL	DFS	Tertile	All	0.133	0.496	.033	9	view →
LIHC	OS	Quartile	III,IV	0.568	0.268	.011	8	view →
ACC	OS	Median	IV	0.344	0.724	.038	6	view →
GBM	OS	Tertile	All	0.322	0.203	.038	5	view →
UCS	DFS	Median	All	0.659	0.425	.026	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

EIF3KP2–DLBC (OS)

Open the DLBC breakdown →